Skip to main content
PMC home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1987 Nov;147(5):569–576.

Clinical Disorders of Phosphorus Metabolism

George C Yu, David B N Lee
PMCID: PMC1025947  PMID: 3321712

Abstract

Deranged phosphorus metabolism is commonly encountered in clinical medicine. Disturbances in phosphate intake, excretion and transcellular shift account for the abnormal serum levels. As a result of the essential role played by phosphate in intracellular metabolism, the clinical manifestations of hypophosphatemia and hyperphosphatemia are extensive. An understanding of the pathophysiology of various phosphate disorders is helpful in guiding therapeutic decisions.

Full text

PDF
569

Images in this article

572Image
on p.572

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abrams D. E., Silcott R. B., Terry R., Berne T. V., Barbour B. H. Antacid induction of phosphate depletion syndrome in renal failure. West J Med. 1974 Feb;120(2):157–160. [PMC free article] [PubMed] [Google Scholar]
  2. Anderson D. C., Peters T. J., Stewart W. K. Association of hypokalaemia and hypophosphataemia. Br Med J. 1969 Nov 15;4(5680):402–403. doi: 10.1136/bmj.4.5680.402. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Aubier M., Murciano D., Lecocguic Y., Viires N., Jacquens Y., Squara P., Pariente R. Effect of hypophosphatemia on diaphragmatic contractility in patients with acute respiratory failure. N Engl J Med. 1985 Aug 15;313(7):420–424. doi: 10.1056/NEJM198508153130705. [DOI] [PubMed] [Google Scholar]
  4. BIJVOET O. L., MAJOOR C. L. THE RENAL TUBULAR REABSORPTION OF PHOSPHATE IN THYROTOXICOSIS. Clin Chim Acta. 1965 Feb;11:181–183. doi: 10.1016/0009-8981(65)90213-5. [DOI] [PubMed] [Google Scholar]
  5. Beck L. H., Goldberg M. Effects of acetazolamide and parathyroidectomy on renal transport of sodium, calcium, and phosphate. Am J Physiol. 1973 May;224(5):1136–1142. doi: 10.1152/ajplegacy.1973.224.5.1136. [DOI] [PubMed] [Google Scholar]
  6. Bijvoet O. L., Morgan D. B., Fourman P. The assessment of phosphate reabsorption. Clin Chim Acta. 1969 Oct;26(1):15–24. doi: 10.1016/0009-8981(69)90280-0. [DOI] [PubMed] [Google Scholar]
  7. Bode J. C., Zelder O., Rumpelt H. J., Wittkamp U. Depletion of liver adenosine phosphates and metabolic effects of intravenous infusion of fructose or sorbitol in man and in the rat. Eur J Clin Invest. 1973 Sep;3(5):436–441. doi: 10.1111/j.1365-2362.1973.tb02211.x. [DOI] [PubMed] [Google Scholar]
  8. Brereton H. D., Anderson T., Johnson R. E., Schein P. S. Hyperphosphatemia and hypocalcemia in Burkitt lymophoma. Complications of chemotherapy. Arch Intern Med. 1975 Feb;135(2):307–309. [PubMed] [Google Scholar]
  9. Colman P., Firkin B. G., van der Weyden M. B. Severe hypophosphataemia in T-cell lymphoblastic lymphoma. Br Med J (Clin Res Ed) 1983 Jan 8;286(6359):105–106. doi: 10.1136/bmj.286.6359.105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Craddock P. R., Yawata Y., VanSanten L., Gilberstadt S., Silvis S., Jacob H. S. Acquired phagocyte dysfunction. A complication of the hypophosphatemia of parenteral hyperalimentation. N Engl J Med. 1974 Jun 20;290(25):1403–1407. doi: 10.1056/NEJM197406202902504. [DOI] [PubMed] [Google Scholar]
  11. Daniels R. A., Weisenfeld I. Tumorous phosphaturic osteomalacia. Report of a case associated with multiple hemangiomas of bone. Am J Med. 1979 Jul;67(1):155–159. doi: 10.1016/0002-9343(79)90097-4. [DOI] [PubMed] [Google Scholar]
  12. David D. S., Sakai S., Brennan B. L., Riggio R. A., Cheigh J., Stenzel K. H., Rubin A. L., Sherwood L. M. Hypercalcemia after renal transplantation. Long-term follow-up data. N Engl J Med. 1973 Aug 23;289(8):398–401. doi: 10.1056/NEJM197308232890804. [DOI] [PubMed] [Google Scholar]
  13. De Vries H. R., Bijvoet O. L. Results of prolonged treatment of Paget's disease of bone with disodium ethane-1-hydroxy-1, 1-diphosphonate (EHDP). Neth J Med. 1974;17(6):281–298. [PubMed] [Google Scholar]
  14. Fuller T. J., Nichols W. W., Brenner B. J., Peterson J. C. Reversible depression in myocardial performance in dogs with experimental phosphorus deficiency. J Clin Invest. 1978 Dec;62(6):1194–1200. doi: 10.1172/JCI109239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Knochel J. P., Barcenas C., Cotton J. R., Fuller T. J., Haller R., Carter N. W. Hypophosphatemia and rhabdomyolysis. J Clin Invest. 1978 Dec;62(6):1240–1246. doi: 10.1172/JCI109244. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Knochel J. P. Hypophosphatemia in the alcoholic. Arch Intern Med. 1980 May;140(5):613–615. [PubMed] [Google Scholar]
  17. Knochel J. P. Hypophosphatemia. West J Med. 1981 Jan;134(1):15–26. [PMC free article] [PubMed] [Google Scholar]
  18. Knochel J. P. Neuromuscular manifestations of electrolyte disorders. Am J Med. 1982 Mar;72(3):521–535. doi: 10.1016/0002-9343(82)90522-8. [DOI] [PubMed] [Google Scholar]
  19. Knochel J. P. The pathophysiology and clinical characteristics of severe hypophosphatemia. Arch Intern Med. 1977 Feb;137(2):203–220. [PubMed] [Google Scholar]
  20. Knox F. G., Osswald H., Marchand G. R., Spielman W. S., Haas J. A., Berndt T., Youngberg S. P. Phosphate transport along the nephron. Am J Physiol. 1977 Oct;233(4):F261–F268. doi: 10.1152/ajprenal.1977.233.4.F261. [DOI] [PubMed] [Google Scholar]
  21. Koffler A., Friedler R. M., Massry S. G. Acute renal failure due to nontraumatic rhabdomyolysis. Ann Intern Med. 1976 Jul;85(1):23–28. doi: 10.7326/0003-4819-85-1-23. [DOI] [PubMed] [Google Scholar]
  22. Kreisberg R. A. Diabetic ketoacidosis: new concepts and trends in pathogenesis and treatment. Ann Intern Med. 1978 May;88(5):681–695. doi: 10.7326/0003-4819-88-5-681. [DOI] [PubMed] [Google Scholar]
  23. Kreusser W., Vetter H. O., Mittmann U., Hörl W. H., Ritz E. Haemodynamics and myocardial metabolism of phosphorus depleted dogs: effects of catecholamines and angiotensin II. Eur J Clin Invest. 1982 Jun;12(3):219–228. doi: 10.1111/j.1365-2362.1982.tb00996.x. [DOI] [PubMed] [Google Scholar]
  24. Lee D. B., Drinkard J. P., Rosen V. J., Gonick H. C. The adult Fanconi syndrome: observations on etiology, morphology, renal function and mineral metabolism in three patients. Medicine (Baltimore) 1972 Mar;51(2):107–138. [PubMed] [Google Scholar]
  25. Leehey D. J., Daugirdas J. T., Ing T. S., Reid R. W. Spurious hyperphosphatemia due to hyperlipidemia. Arch Intern Med. 1985 Apr;145(4):743–744. [PubMed] [Google Scholar]
  26. Lennquist S., Lindell B., Nordström H., Sjöberg H. E. Hypophosphatemia in severe burns. A prospective study. Acta Chir Scand. 1979;145(1):1–6. [PubMed] [Google Scholar]
  27. Lentz R. D., Brown D. M., Kjellstrand C. M. Treatment of severe hypophosphatemia. Ann Intern Med. 1978 Dec;89(6):941–944. doi: 10.7326/0003-4819-89-6-941. [DOI] [PubMed] [Google Scholar]
  28. Lichtman M. A., Miller D. R., Cohen J., Waterhouse C. Reduced red cell glycolysis, 2, 3-diphosphoglycerate and adenosine triphosphate concentration, and increased hemoglobin-oxygen affinity caused by hypophosphatemia. Ann Intern Med. 1971 Apr;74(4):562–568. doi: 10.7326/0003-4819-74-4-562. [DOI] [PubMed] [Google Scholar]
  29. Lotz M., Zisman E., Bartter F. C. Evidence for a phosphorus-depletion syndrome in man. N Engl J Med. 1968 Feb 22;278(8):409–415. doi: 10.1056/NEJM196802222780802. [DOI] [PubMed] [Google Scholar]
  30. Massara F., Camanni F. Propranolol block of adrenaline-induced hypophosphataemia in man. Clin Sci. 1970 Feb;38(2):245–250. doi: 10.1042/cs0380245. [DOI] [PubMed] [Google Scholar]
  31. Morris R. C., Jr, Nigon K., Reed E. B. Evidence that the severity of depletion of inorganic phosphate determines the severity of the disturbance of adenine nucleotide metabolism in the liver and renal cortex of the fructose-loaded rat. J Clin Invest. 1978 Jan;61(1):209–220. doi: 10.1172/JCI108920. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Narins R. G., Jones E. R., Stom M. C., Rudnick M. R., Bastl C. P. Diagnostic strategies in disorders of fluid, electrolyte and acid-base homeostasis. Am J Med. 1982 Mar;72(3):496–520. doi: 10.1016/0002-9343(82)90521-6. [DOI] [PubMed] [Google Scholar]
  33. Nusynowitz M. L., Frame B., Kolb F. O. The spectrum of the hypoparathyroid states: A classification based on physiologic principles. Medicine (Baltimore) 1976 Mar;55(2):105–119. doi: 10.1097/00005792-197603000-00001. [DOI] [PubMed] [Google Scholar]
  34. O'Connor L. R., Klein K. L., Bethune J. E. Hyperphosphatemia in lactic acidosis. N Engl J Med. 1977 Sep 29;297(13):707–709. doi: 10.1056/NEJM197709292971307. [DOI] [PubMed] [Google Scholar]
  35. O'Connor L. R., Wheeler W. S., Bethune J. E. Effect of hypophosphatemia on myocardial performance in man. N Engl J Med. 1977 Oct 27;297(17):901–903. doi: 10.1056/NEJM197710272971702. [DOI] [PubMed] [Google Scholar]
  36. OKEL B. B., HURST J. W. Prolonged hyperventilation in man. Associated electrolyte changes and subjective symptoms. Arch Intern Med. 1961 Nov;108:757–762. doi: 10.1001/archinte.1961.03620110097013. [DOI] [PubMed] [Google Scholar]
  37. Parfitt A. M. The spectrum of hypoparathyroidism. J Clin Endocrinol Metab. 1972 Jan;34(1):152–158. doi: 10.1210/jcem-34-1-152. [DOI] [PubMed] [Google Scholar]
  38. Pollock R. A., Watson R. L. Malignant hyperthermia associated with hypocalcemia. Anesthesiology. 1971 Feb;34(2):188–194. doi: 10.1097/00000542-197102000-00027. [DOI] [PubMed] [Google Scholar]
  39. Prince M. J., Schaeffer P. C., Goldsmith R. S., Chausmer A. B. Hyperphosphatemic tumoral calcinosis: association with elevation of serum 1,25-dihydroxycholecalciferol concentrations. Ann Intern Med. 1982 May;96(5):586–591. doi: 10.7326/0003-4819-96-5-586. [DOI] [PubMed] [Google Scholar]
  40. Shackney S., Hasson J. Precipitous fall in serum calcium, hypotension, and acute renal failure after intravenous phosphate therapy for hypercalcemia. Report of two cases. Ann Intern Med. 1967 May;66(5):906–916. doi: 10.7326/0003-4819-66-5-906. [DOI] [PubMed] [Google Scholar]
  41. Silvis S. E., Paragas P. D., Jr Paresthesias, weakness, seizures, and hypophosphatemia in patients receiving hyperalimentation. Gastroenterology. 1972 Apr;62(4):513–520. [PubMed] [Google Scholar]
  42. Slatopolsky E., Robson A. M., Elkan I., Bricker N. S. Control of phosphate excretion in uremic man. J Clin Invest. 1968 Aug;47(8):1865–1874. doi: 10.1172/JCI105877. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Slatopolsky E., Rutherford W. E., Rosenbaum R., Martin K., Hruska K. Hyperphosphatemia. Clin Nephrol. 1977 Apr;7(4):138–146. [PubMed] [Google Scholar]
  44. Slatopolsky E., Weerts C., Lopez-Hilker S., Norwood K., Zink M., Windus D., Delmez J. Calcium carbonate as a phosphate binder in patients with chronic renal failure undergoing dialysis. N Engl J Med. 1986 Jul 17;315(3):157–161. doi: 10.1056/NEJM198607173150304. [DOI] [PubMed] [Google Scholar]
  45. WHANG R., WELT L. G. Observations in experimental magnesium depletion. J Clin Invest. 1963 Mar;42:305–313. doi: 10.1172/JCI104717. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Yawata Y., Hebbel R. P., Silvis S., Howe R., Jacob H. Blood cell abnormalities complicating the hypophosphatemia of hyperalimentation: erythrocyte and platelet ATP deficiency associated with hemolytic anemia and bleeding in hyperalimented dogs. J Lab Clin Med. 1974 Nov;84(5):643–653. [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES